8 Calcium control of adenylyl cyclase: The calcineurin connection

Advances in Second Messenger and Phosphoprotein Research

Volumn 32, Issue C, 1997, Pages 153-172

  Antoni, Ferenc A ^a   Smith, Susan M ^a   Simpson, James ^a   Rosie, Roberta ^a   Fink, George ^a   Paterson, Janice M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCINEURIN; CALCIUM;

AMINO ACID SEQUENCE; ANIMAL; CELL FREE SYSTEM; CELL LINE; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SEQUENCE HOMOLOGY;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; CALCINEURIN; CALCIUM; CELL LINE; CELL-FREE SYSTEM; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0031615567     PISSN: 10407952     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1040-7952(98)80010-4     Document Type: Article

References (76)

1. Krupinski, J, Coussen, F, Bakalyar, HA, et al. AC amino acid sequence: possible channel- or transporter-like structure. Science 244 (1989), 1558-1564.
2. Cooper, DMF, Mons, N, Karpen, JW, Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374 (1995), 421-424.
3. Antoni, FA, Calcium regulation of adenylyl cyclase—relevance for endocrine control. Trends Endocrinol Metab 8 (1996), 7-14.
4. Sunahara, RK, Dessauer, CW, Gilman, AG, Complexity and diversity of mammalian adenylyl cyclases. Ann Rev Biochem 36 (1996), 461-480.
5. Tang, WJ, Stanzel, M, Gilman, AG, Truncation and alanine-scanning mutants of type-1 adenylyl-cyclase. Biochemistry 34 (1995), 14563-14572.
6. Levin, LR, Reed, RR, Identification of functional domains of adenylyl cyclase using in vivo chimeras. J Biol Chem 270 (1995), 7573-7579.
7. Taussig, R, Gilman, AG, Mammalian membrane-bound adenylyl cyclases. J Biol Chem 270 (1995), 1-4.
8. s-regulated adenylyl cyclases. Brown, BL, Dobson, PRM, (eds.) Advances in second messenger and phosphoprotein research, 1993, Raven Press, New York, 27-36.
9. Paterson, JM, Smith, SM, Harmar, AJ, Antoni, FA, Control of a novel adenylyl cyclase by calcineurin. Biochem Biophys Res Commun 214 (1995), 1000-1008.
10. Premont, RT, Identification of adenylyl cyclases by amplification using degenerate primers. Methods Enzymol 238 (1994), 116-127.
11. Harmar, AJ, Lutz, EM, Multiple receptors for PACAP and VIP. Trends Pharmacol Sci 15 (1994), 97-99.
12. Antoni, FA, Calcium checks cyclic AMP: mechanism of corticosteroid feedback in adenohypophysial corticotrophs. J Neuroendocrinol 8 (1996), 659-672.
13. iα. Science 261 (1993), 219-221.
14. Jacobowitz, O, Iyengar, R, Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc Natl Acad Sci USA 91 (1994), 10630-10634.
15. Ang, KL, Antoni, FA, Rolipram-inhibitable cyclic nucleotide phosphodiesterase (PDE) in rat adeno-hypophysis: Potential functional role in corticotrophs and somatotrophs. Br J Pharmacol, 119, 1996, 361.
16. Baimbridge, K, Celio, M, Rogers, J, Calcium binding proteins in the nervous system. Trends Neurosci 15 (1992), 303-308.
17. Epstein, PN, Ribar, TJ, Decker, GL, et al. Elevated β-cell calmodulin produces a unique insulin secretory defect in transgenic mice. Endocrinology 130 (1992), 1387-1393.
18. 2+ oscillations in HEK-293 cells. J Biol Chem 270 (1995), 24108-24115.
19. 2+ channels by β-adrenergic agonists. Proc Natl Acad Sci USA 93 (1996), 295-299.
20. Premont, RT, Matsuoka, I, Mattei, M-G, et al. Identification and characterization of a widely expressed from of adenylyl cyclase. J Biol Chem 271 (1996), 13900-13907.
21. Antoni, FA, Barnard, RJO, Shipston, MJ, et al. Calcineurin feedback inhibition of agonist-evoked cAMP formation. J Biol Chem 270 (1995), 28055-28061.
22. Klee, CB, Cohen, P, The calmodulin regulated protein phosphatase. Cohen, P, Klee, CB, (eds.) Calmodulin, 1988, Elsevier, Amsterdam, 225-245.
23. Liu, J, Farmer, JD Jr, Lane, WS, et al. Calcineurin is a common target of cyclophylin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991), 807-815.
24. Fischer, G, Peptidyl-prolyl cis/trans isomerases and their effectors. Angewandte chemie-international edition in english 33 (1994), 1415-1436.
25. Schreiber, SL, Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 70 (1992), 365-368.
26. Sigal, NH, Dumont, FJ, Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Ann Rev Immunol 10 (1992), 519-560.
27. Cardenas, M, Hemenway, C, Muir, RS, et al. Immunophilins interact with calcineurin in the the absence of exogenous immunosuppressive ligands. EMBO J 13 (1994), 5944-5957.
28. 2+ flux. Cell 83 (1995), 463-472.
29. Pahl, A, Keller, U, FK-506-binding proteins from Streptomycetes producing immunosuppressive macrolactones of the FK-506 type. J Bacteriol 174 (1992), 5888-5894.
30. Kissinger, CR, Parge, HE, Knighton, DR, et al. Crystal-structures of human calcineurin and the human FKBP 12-FK506-calcineurin complex. Nature 378 (1995), 641-644.
31. Griffith, JP, Kim, JL, Kim, EE, et al. X-ray structure of calcineurin inhibited by the immunophilin immunosuppressant FKBP12-FK506 complex. Cell 82 (1995), 507-522.
32. Coghlan, VM, Perrino, BA, Howard, M, et al. Association of protein-kinase-A and protein-phosphatase-2B with a common anchoring protein. Science 267 (1995), 108-111.
33. Wesselborg, S, Fruman, DA, Sagoo, JK, et al. Identification of a physical interaction between calcineurin and nuclear factor of activated T-cells (NFATP). J. Biol Chem 271 (1996), 1274-1277.
34. Loh, C, Shaw, KTY, Carew, J, et al. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 271 (1996), 10884-10891.
35. Rosen, MK, Yang, D, Martin, PK, Schreiber, SL, Activation of an inactive immunophilin by mutagenesis. J Am Chem Soc 115 (1993), 821-822.
36. Yang, D, Rosen, MK, Schreiber, SL, A composite FKBP12-FK506 surface that contacts calcineurin. J Am Chem Soc 115 (1993), 819-820.
37. Aldape, RA, Futer, O, DeCenzo, MT, et al. Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex. J Biol Chem 267 (1992), 16029-16032.
38. Braun, W, Kallen, J, Mikol, V, et al. Three-dimensional structure and actions of immunosuppressants and their immunophilins. FASEB J 9 (1995), 63-72.
39. Vorherr, T, Knopfel, L, Hofmann, F, et al. The calmodulin-binding domain of nitric oxide synthase and adenylyl cyclase. Biochemistry (USA) 32 (1993), 6081-6088.
40. Wu, Z, Wong, ST, Strom, DR, Modification of the calcium and calmodulin sensitivity of the type I adenylyl cyclase by mutagenesis of its calmodulin binding domain. J Biol Chem 286 (1993), 23766-23768.
41. 2+/calmodulin. J Biol Chem 271 (1996), 1089-1095.
42. Paterson, J, Simpson, J, Antoni, F, Dephosphorylation of the C1b segment of adenylyl cyclase type 9 by calcineurin. Biochem Soc Trans, 24, 1996, 583S.
43. 2+-sensitive adenylyl cyclases. Biochem J 297 (1994), 437-440.
44. s-alpha. Mol Endocrinol 9 (1995), 1279-1287.
45. Antoni, FA, Hoyland, J, Woods, MD, Mason, WT, Glucocorticoid inhibition of stimulus-evoked adrenocorticotrophin release caused by suppression of intracellular calcium signals. J Endocrinol 133 (1992), R13–R16.
46. (i) depend on external calcium and the activation of L-type voltage-gated calcium channels in a clonal pituitary cell-line (AtT-20) of cultured mouse corticotropes. Cell Calcium 19 (1996), 327-336.
47. Collins, JH, Sequence-analysis of the ryanodine receptor-possible association with a 12K, FK506-binding immunophilin protein-kinase-C inhibitor. Biochem Biophys Res Commun 178 (1991), 1288-1290.
48. 2+-release channels from cardiac-muscle. Circ Res 78 (1996), 990-997.
49. Antoni, FA, Shipston, MJ, Smith, SM, Inhibitory role for calcineurin in stimulus secretion coupling revealed by FK506 and cyclosporin A in pituitary corticotrope tumor cells. Biochem Biophys Res Commun 194 (1993), 226-233.
50. Antoni, FA, Shipston, MJ, Woods, MD, et al. Secretagogue glucocorticoid interactions in the control of anterior pituitary adrenocorticotrophin (ACTH) secretion. Mornex, R, Jaffiol, C, Leclère, J, (eds.) Progress in endocrinology: proceedings of the Ninth International Congress of Endocrinology, Nice 1992, 1993, Parthenon Publishers, Carnforth, UK, 530-535.
51. Blumenthal, DK, Takio, K, Hansen, RS, Krebs, EG, Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (TypeII) by calmodulin-dependent protein phosphatase. J Biol Chem 261 (1986), 8140-8145.
52. Xia, ZG, Refsdal, CD, Merchant, KM, et al. Distribution of messenger-RNA for the calmodulin-sensitive adenylate cyclase in rat brain: expression in areas associated with learning and memory. Neuron 6 (1991), 431-443.
53. Mons, N, Cooper, DMF, Adenylate cyclases: critical foci in neuronal signaling. Trends Neurosci 18 (1995), 536-542.
54. 2+-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions. Mol Brain Res 22 (1994), 236-244.
55. Buttini, M, Luyten, M, Limonta, S, Boddeke, H, Distribution of calcineurin A beta isoenzyme mRNAs in rat brain: comparison with the distribution of calcineurin A alpha isoenzyme mRNAs. Neurosci Res Commun 14 (1994), 9-16.
56. Polli, JW, Billingsley, ML, Kincaid, RL, Expression of the calmodulin-dependent protein phosphatase, calcineurin, in rat brain: developmental patterns and the role of nigrostriatal innervation. Dev Brain Res 63 (1991), 105-119.
57. Mulkey, RM, Endo, S, Shenolikar, S, Malenka, RC, Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369 (1994), 486-488.
58. Hodgkiss, JP, Kelly, JS, Only de novo long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex. Brain Res 705 (1995), 241-246.
59. 2+/calmodulin-dependent phosphatase inhibitor inhibits the induction of long-term potentiation in the rat hippocampus. Neurosci Lett 205 (1996), 103-106.
60. Burlet, A, Tonon, MC, Tankosic, P, et al. Comparative immunocytochemical localization of corticotropin releasing-factor (CRF-41) and neurohypophyseal peptides in the brain of Brattleboro and Long-Evans rats. Neuroendocrinology 37 (1983), 64-72.
61. 28K: role in determining intrinsically generated firing patterns in rat supraoptic neurones. J Physiol 488 (1995), 601-608.
62. Köves, K, Görcs, TJ, Arimura, A, Colocalization of PACAP, but not of VIP, with oxytocin in the hypothalamic magnocellular neurons of colchicine treated and pituitary-stalk sectioned rats. Endocrine 2 (1994), 1169-1175.
63. Antoni, FA, Palkovits, M, Makara, GB, et al. Immunoreactive ovine corticotropin-releasing factor (oCRF-LI) in the hypothalamo-hypophyseal tract of the rat. Usdin, E, Axelrod, J, Kvetnansky, R, (eds.) Stress: the role of catecholamines and other neurotransmitters, 1984, Gordon and Breach, New York, 233-241.
64. Rivest, S, Laflamme, N, Nappi, RE, Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci 15 (1995), 2680-2695.
65. Hill, JM, Harris, A, Hiltonclarke, DI, Regional distribution of guanine nucleotide-sensitive and guanine nucleotide-insensitive vasoactive-intestinal-peptide receptors in rat brain. Neuroscience 48 (1992), 925-932.
66. Antoni, FA, Vasopressin and the endocrine response to stress. Neth J Zool 45 (1995), 98-102.
67. 2+-inhibited adenylyl cyclase in cardiac tissue. Trends Pharmacol Sci 14 (1993), 34-36.
68. Baukal, AJ, Hunyady, L, Catt, KJ, Balla, T, Evidence for participation of calcineurin in potentiation of agonist-stimulated cyclic AMP formation by the calcium mobilizing hormone, angiotensin II. J Biol Chem 269 (1994), 24546-24549.
69. Tang, WJ, Krupinski, J, Gilman, AG, Expression and characterisation of calmodulin-activated (type I) adenylyl cyclase. J Biol Chem 266 (1991), 8595-8603.
70. Watson, PA, Krupinski, J, Kempinski, AM, Frankenfield, CD, Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J Biol Chem 269 (1994), 28893-28898.
71. Wu, ZL, Thomas, SA, Villacres, EC, et al. Altered behavior and long-term potentiation in type-I adenylyl-cyclase mutant mice. Proc Natl Acad Sci USA 92 (1995), 220-224.
72. DeBernardi, MA, Munshi, R, Yoshimura, M, et al. Predominant expression of type-VI cyclase in C6-2B rat glioma cells may account for inhibition of cyclic AMP accumulation by calcium. Biochem J 293 (1993), 325-328.
73. Kawabe, J, Ebina, T, Ismail, S, et al. A novel peptide inhibitor of adenylyl cyclase. J Biol Chem 269 (1994), 24906-24911.
74. Chen, J, DeVivo, M, Dingus, J, et al. A region of adenylyl cyclase 2 critical for regulation by G protein bg subunits. Science 268 (1995), 1166-1169.
75. Kerwin, JF Jr, Adenylate cyclase subtypes as molecular drug targets. Annu Rep Med Chem 29 (1994), 287-296.
76. Furukawa, Y, Matsumori, A, Hirozane, T, et al. Immunomodulation by an adenylate-cyclase activator, nkh477, in vivo and in vitro. Clin Immunol Immunopathol 79 (1996), 25-35.